{"id":"NCT01639495","sponsor":"Biosense Webster, Inc.","briefTitle":"THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation CONTINUED ACCESS","officialTitle":"THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation Continued Access","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-07-01","primaryCompletion":"2014-06-01","completion":"2014-10-01","firstPosted":"2012-07-12","resultsPosted":"2018-05-15","lastUpdate":"2018-05-15"},"enrollment":148,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation"],"interventions":[{"type":"DEVICE","name":"THERMOCOOL® SMARTTOUCH™ Catheter","otherNames":[]}],"arms":[{"label":"THERMOCOOL® SMARTTOUCH™ Catheter","type":"EXPERIMENTAL"}],"summary":"This is a prospective, multicenter, non-randomized continued access clinical evaluation utilizing the THERMOCOOL® SMARTTOUCH™ catheter.","primaryOutcome":{"measure":"Percentage of Subjects Achieved Freedom From Atrial Tachyarrhythmias","timeFrame":"Day 91-361","effectByArm":[{"arm":"THERMOCOOL® SMARTTOUCH™ Catheter","deltaMin":60.6,"sd":null}],"pValues":[{"comp":"OG000","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":5},"locations":{"siteCount":20,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":46,"n":144},"commonTop":["Arrhythmia","Pericardial effusion","Haematoma","Atrial fibrillation","Chest pain"]}}